Johnny Uy
23Patents
8h-index
74Co-inventors
74Inventor score
Filing activity: Apr 23, 2008 → Aug 4, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8158647B2 | Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators | Human Necessities | 90 | Active |
| US9782408B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Emerging Cross-Sectional Technologies | 31 | Active |
| US10258624B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Emerging Cross-Sectional Technologies | 29 | Active |
| US10570115B2 | Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator | Chemistry; Metallurgy | 21 | Active |
| US10793547B2 | Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator | Chemistry; Metallurgy | 20 | Active |
| US10758534B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Emerging Cross-Sectional Technologies | 12 | Active |
| US11186566B2 | Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator | Chemistry; Metallurgy | 10 | Active |
| US11066417B2 | Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators | Chemistry; Metallurgy | 8 | Active |
| US11426407B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Emerging Cross-Sectional Technologies | 6 | Active |
| US11453655B2 | Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator | Chemistry; Metallurgy | 6 | Active |
| US10738030B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Chemistry; Metallurgy | 5 | Active |
| US8202891B2 | Quaternary ammonium compounds useful as muscarinic receptor antagonists | Chemistry; Metallurgy | 2 | Active |
| US11866450B2 | Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators | Chemistry; Metallurgy | 1 | Active |
| US12168009B2 | Modulators of cystic fibrosis transmembrane conductance regulator | Emerging Cross-Sectional Technologies | 1 | Active |
| US12384762B2 | Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator | Chemistry; Metallurgy | 0 | Active |
| US8492407B2 | Quaternary ammonium compounds useful as muscarinic receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US9216971B2 | Quaternary ammonium compounds useful as muscarinic receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US10233191B2 | Fused piperidine amides as modulators of ion channels | Chemistry; Metallurgy | 0 | Active |
| US10385070B2 | Chroman-spirocyclic piperidine amides as modulators of ion channels | Chemistry; Metallurgy | 0 | Active |
| US9403839B2 | Pyran-spirocyclic piperidine amides as modulators of ion channels | Human Necessities | 0 | Active |
| US12421251B2 | Cystic fibrosis transmembrane conductance regulator modulating agents | Chemistry; Metallurgy | 0 | Active |
| US9365588B2 | Benzoxazines as modulators of ion channels | Chemistry; Metallurgy | 0 | Active |
| US8815907B2 | Quaternary ammonium compounds useful as muscarinic receptor antagonists | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.